70 related articles for article (PubMed ID: 22459575)
1. [Identification of clinical features and laboratory abnormalities associated with the development of vertebral fractures in women with postmenopausal osteoporosis].
Cerdà D; Peris P; Monegal A; Albaladejo C; Surís X; Guañabens N
Med Clin (Barc); 2012 Dec; 139(14):626-30. PubMed ID: 22459575
[TBL] [Abstract][Full Text] [Related]
2. Independent predictors of all osteoporosis-related fractures among healthy Saudi postmenopausal women: the CEOR Study.
Rouzi AA; Al-Sibiani SA; Al-Senani NS; Radaddi RM; Ardawi MS
Bone; 2012 Mar; 50(3):713-22. PubMed ID: 22178778
[TBL] [Abstract][Full Text] [Related]
3. Does Rheumatoid Cachexia Predispose Patients with Rheumatoid Arthritis to Osteoporosis and Vertebral Fractures?
El Maghraoui A; Sadni S; Rezqi A; Bezza A; Achemlal L; Mounach A
J Rheumatol; 2015 Sep; 42(9):1556-62. PubMed ID: 26233497
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of vertebral fractures and minor vertebral deformities evaluated by DXA-assisted vertebral fracture assessment (VFA) in a population-based study of postmenopausal women: the FRODOS study.
Kanterewicz E; Puigoriol E; García-Barrionuevo J; del Rio L; Casellas M; Peris P;
Osteoporos Int; 2014 May; 25(5):1455-64. PubMed ID: 24599272
[TBL] [Abstract][Full Text] [Related]
5. Low bone mineral density, but not epidural steroid injection, is associated with fracture in postmenopausal women with low back pain.
Yi Y; Hwang B; Son H; Cheong I
Pain Physician; 2012; 15(6):441-9. PubMed ID: 23159959
[TBL] [Abstract][Full Text] [Related]
6. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.
Yamamoto M; Yamaguchi T; Nawata K; Yamauchi M; Sugimoto T
J Clin Endocrinol Metab; 2012 Apr; 97(4):1277-84. PubMed ID: 22337915
[TBL] [Abstract][Full Text] [Related]
7. Vertebral fracture prevalence in a referral population of 750 Canadian men and women.
Yakemchuk V; Beaumont LF; Webber CE; Gulenchyn KY; Jager PL
Clin Radiol; 2012 Nov; 67(11):1061-8. PubMed ID: 22959172
[TBL] [Abstract][Full Text] [Related]
8. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
[TBL] [Abstract][Full Text] [Related]
9. Use of clinical risk factors to identify postmenopausal women with vertebral fractures.
Tobias JH; Hutchinson AP; Hunt LP; McCloskey EV; Stone MD; Martin JC; Thompson PW; Palferman TG; Bhalla AK
Osteoporos Int; 2007 Jan; 18(1):35-43. PubMed ID: 16951907
[TBL] [Abstract][Full Text] [Related]
10. Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women.
El Maghraoui A; Rezqi A; El Mrahi S; Sadni S; Ghozlani I; Mounach A
BMC Endocr Disord; 2014 Dec; 14():93. PubMed ID: 25492884
[TBL] [Abstract][Full Text] [Related]
11. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
[TBL] [Abstract][Full Text] [Related]
12. Associations between body composition and vertebral fracture risk in postmenopausal women.
Kuo DP; Chiu YW; Chen PT; Tsai YJ; Hou CH; Chen YL; Chu CM
Osteoporos Int; 2022 Mar; 33(3):589-598. PubMed ID: 34626209
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of vertebral fractures and quality of life in a sample of postmenopausal Brazilian women with osteoporosis.
de Oliveira Ferreira N; da Silva RB; Arthuso M; Pinto-Neto AM; Caserta N; Costa-Paiva L
Arch Osteoporos; 2012; 7():101-6. PubMed ID: 23225287
[TBL] [Abstract][Full Text] [Related]
14. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
[TBL] [Abstract][Full Text] [Related]
16. [Influence on adjacent lumbar bone density after strengthening of T12, L1 segment vertebral osteoporotic compression fracture by percutaneous vertebroplasty and percutaneous kyphoplasty].
Zhang C; Zhu K; Zhou J; Zhou X; Niu G; Wu M; Shao C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):819-23. PubMed ID: 24063170
[TBL] [Abstract][Full Text] [Related]
17. Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?
Bagger YZ; Rasmussen HB; Alexandersen P; Werge T; Christiansen C; Tankó LB;
Osteoporos Int; 2007 Apr; 18(4):505-12. PubMed ID: 17109061
[TBL] [Abstract][Full Text] [Related]
18. Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease.
Ogura-Tomomatsu H; Asano K; Tomomatsu K; Miyata J; Ohmori N; Kodama M; Ueda S; Takihara T; Tanaka K; Kamiishi N; Suzuki Y; Fukunaga K; Oguma T; Sayama K; Betsuyaku T
COPD; 2012 Aug; 9(4):332-7. PubMed ID: 22489911
[TBL] [Abstract][Full Text] [Related]
19. Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: a population survey of older men and women.
Leidig-Bruckner G; Limberg B; Felsenberg D; Bruckner T; Holder S; Kather A; Miksch J; Wüster C; Ziegler R; Scheidt-Nave C
Osteoporos Int; 2000; 11(2):102-19. PubMed ID: 10793868
[TBL] [Abstract][Full Text] [Related]
20. Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk.
Boonen S; Adachi JD; Man Z; Cummings SR; Lippuner K; Törring O; Gallagher JC; Farrerons J; Wang A; Franchimont N; San Martin J; Grauer A; McClung M
J Clin Endocrinol Metab; 2011 Jun; 96(6):1727-36. PubMed ID: 21411557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
